Sana Biotechnology

Yahoo Finance • yesterday

Sana (SANA) Surges 14.5% Ahead of Business Announcements

We recently published 10 Small Stocks with Mighty Gains. Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top-performing stocks on Wednesday. Sana Biotechnology soared by 14.53 percent on Wednesday to finish at $4.02 apiece as investo... Full story

Yahoo Finance • 5 days ago

Sana Biotechnology to Present at December 2025 Investor Conferences

SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor... Full story

Yahoo Finance • 10 days ago

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care

Issued on behalf of Avant Technologies Inc. VANCOUVER, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies ra... Full story

Yahoo Finance • 11 days ago

Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength

Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America Securities analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology (NASDAQ: SANA) and set a price target of... Full story

Yahoo Finance • 29 days ago

The Math Shows FHLC Can Go To $79

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • last month

Sana Biotech surges as Eric Jackson calls it a 100-bagger

[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Dragon Claws/iStock via Getty Images Shares of Sana Biotechnology (NASDAQ:SANA [https://seekingalpha.co... Full story

Yahoo Finance • 2 months ago

TruBridge, Inc. (TBRG): A Bull Case Theory

We came across a bullish thesis on TruBridge, Inc. (TBRG) on Negócios pelo Mundo’s Substack by Leo Caroli. In this article, we will summarize the bulls’ thesis on TBRG. TruBridge, Inc. (TBRG)'s share was trading at $21.79 as of September 1... Full story

Yahoo Finance • 3 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the biop... Full story

Yahoo Finance • 3 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor... Full story

Yahoo Finance • 3 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 share... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology prices $75 million public offering at $3.35 per share

SEATTLE - Sana Biotechnology, Inc. (NASDAQ:SANA), whose stock has surged over 160% year-to-date with a current market capitalization of approximately $959 million, has priced its underwritten public offering of 20,895,522 shares of common... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35

* Sana Biotechnology (NASDAQ:SANA [https://seekingalpha.com/symbol/SANA]) priced [https://seekingalpha.com/pr/20192464-sana-biotechnology-announces-pricing-of-public-offering] its underwritten public offering of ~20.89M shares at $3.35 p... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology Announces Pricing of Public Offering

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public off... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public o... Full story

Yahoo Finance • 4 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics, Inc. Following FDA input, Seres submitted Phase 2 study protocol to FDA for SER-155 for the prevention of bloodstream infections (BSIs) in adults undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) to... Full story

Yahoo Finance • 4 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Tran... Full story

Yahoo Finance • 4 months ago

Citi Maintained a Buy Rating on Sana Biotechnology (SANA)

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the Best American Penny Stocks to Buy According to Analysts.On July 2, Citi analyst Samantha Semenkow maintained a Buy rating on Sana Biotechnology, Inc. (NASDAQ:SANA) with a price target of... Full story

Yahoo Finance • 5 months ago

Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 price target and Market Outperform rating for Sana Biotechnology, Inc. (NASDAQ:SANA) in light of new clinical data... Full story

Yahoo Finance • 5 months ago

Morgan Stanley initiates Sana Biotechnology stock with Overweight rating

Investing.com - Morgan Stanley has initiated coverage on Sana Biotechnology (NASDAQ:SANA) with an Overweight rating and a $12.00 price target, joining a broader analyst consensus that sees significant upside potential. The stock, which h... Full story

Yahoo Finance • 5 months ago

Sana Biotechnology's SWOT analysis: promising cell therapy stock faces crowded market

Sana Biotechnology , Inc. (NASDAQ:SANA), a clinical-stage biotechnology company with a market capitalization of $645 million, has been making significant strides in the field of cell therapy. According to InvestingPro data, the stock has s... Full story